PhD Programs in Biomedical Science

Person working in a lab

PIBS

An interdisciplinary umbrella program allows you to explore a variety of research opportunities before committing to a program, making your path flexible and adaptable.

 

Flexible Pathways

The Program in Biomedical Sciences (PIBS) is designed to offer students maximum flexibility during the first year of graduate studies. PIBS students receive full funding and benefits and can immediately begin training in one program or take a course of study compatible with several programs while completing research rotations. You can rotate with any of our 500+ faculty that make up one of the largest and most vibrant research communities in the country. At the end of the PIBS year, you choose a permanent program and will continue to be funded through defense and graduation.

Our team of support staff, program directors and academic advisors will help you pursue a career path of your choosing. From initial course selection, to exploring certificates and dual degrees, and finding a postdoc, we’re here for you!

Explore PIBS Programs

*In addition to admission through PIBS, these programs offer direct admission.
  • *Bioinformatics
  • Biological Chemistry
  • Cancer Biology
  • Cell & Developmental Biology
  • Cellular & Molecular Biology
  • *Genetics & Genomics
  • *Health Infrastructures & Learning Systems
  • Immunology
  • Microbiology & Immunology
  • *Molecular, Cellular & Developmental Biology
  • Molecular & Cellular Pathology
  • Molecular & Integrative Physiology
  • *Neuroscience
  • Pharmacology

    • Explore PIBS Faculty

    The 500+ faculty affiliated with PIBS are engaged in interdisciplinary research projects and collaborations through the university and the world!

    The PIBS Faculty Database allows you to search by name, program or research topic.

    News Across PIBS Programs

     See All News Across PIBS Programs     Michelle Hastings, Ph.D. and lab member look at molecule on computer screen.
    News Release

    $3.9 million NIH grant to fuel U-M effort to develop first targeted therapy for fatal childhood brain disorder

    A team led by Dr. Michelle Hastings will advance a new RNA-based medicine for the most common form of CLN3 Batten disease toward clinical trials
         Father comforts sick child
    News Release

    15 years of data will help uncover how flu spreads—and how to reduce its impact

    $14.2-million NIH award to University of Michigan funds research to untangle intricacies of person-to-person flu transmission—and reduce illness, deaths, economic losses
         cells close up blue and green background microscope
    Health Lab

    Engineered nanoparticles sensitize gliomas to radiotherapy

    University of Michigan researchers discovered a new pathway that sensitizes mIDH1 gliomas to radiation in human and mouse mIDH1 glioma cells and mouse models, paving the way for phase 1 clinical trials in humans
         Francis Collins MD PhD needle haystack
    News Release

    A gene discovery that changed cystic fibrosis care, and genetic research, forever

    Modern cystic fibrosis care at U-M Health includes medication based on genetic discoveries as well as many other options